心血管

订阅

MedSci主页 / 所有栏目 / 心血管

心律失常如何合理制定更优的治疗方案？

2021-07-14 MedSci原创 MedSci原创

心律失常
关注

如何合理制定最优的治疗方案？

《梅斯医学课：心律失常的临床诊断与心电图分析 》

回答问题1：如何合理制定最优的治疗方案？

 

欢迎点赞、评论、分享

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1905174, encodeId=62dc19051e4db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun May 01 23:01:15 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999551, encodeId=5f4f9995510d, content=很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/3ef5dd581a1f4fa7a128a1117752b798/bd2dd05bc98743a4b1da7fa7fba967a7.jpg, createdBy=8b395549160, createdName=热带鱼哦哦, createdTime=Wed Jul 14 21:38:34 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999549, encodeId=aecb999549ee, content=高级, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5145541640, createdName=ms1000001425826697, createdTime=Wed Jul 14 21:30:16 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999494, encodeId=c71199949405, content=规律用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Wed Jul 14 18:53:20 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999485, encodeId=bfd0999485c8, content=完美, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeb04884224, createdName=1220956865, createdTime=Wed Jul 14 18:06:38 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2022-05-01 zhangjiqing

    #治疗方案#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1905174, encodeId=62dc19051e4db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun May 01 23:01:15 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999551, encodeId=5f4f9995510d, content=很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/3ef5dd581a1f4fa7a128a1117752b798/bd2dd05bc98743a4b1da7fa7fba967a7.jpg, createdBy=8b395549160, createdName=热带鱼哦哦, createdTime=Wed Jul 14 21:38:34 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999549, encodeId=aecb999549ee, content=高级, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5145541640, createdName=ms1000001425826697, createdTime=Wed Jul 14 21:30:16 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999494, encodeId=c71199949405, content=规律用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Wed Jul 14 18:53:20 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999485, encodeId=bfd0999485c8, content=完美, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeb04884224, createdName=1220956865, createdTime=Wed Jul 14 18:06:38 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 热带鱼哦哦

    很受益

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1905174, encodeId=62dc19051e4db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun May 01 23:01:15 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999551, encodeId=5f4f9995510d, content=很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/3ef5dd581a1f4fa7a128a1117752b798/bd2dd05bc98743a4b1da7fa7fba967a7.jpg, createdBy=8b395549160, createdName=热带鱼哦哦, createdTime=Wed Jul 14 21:38:34 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999549, encodeId=aecb999549ee, content=高级, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5145541640, createdName=ms1000001425826697, createdTime=Wed Jul 14 21:30:16 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999494, encodeId=c71199949405, content=规律用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Wed Jul 14 18:53:20 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999485, encodeId=bfd0999485c8, content=完美, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeb04884224, createdName=1220956865, createdTime=Wed Jul 14 18:06:38 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 ms1000001425826697

    高级

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1905174, encodeId=62dc19051e4db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun May 01 23:01:15 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999551, encodeId=5f4f9995510d, content=很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/3ef5dd581a1f4fa7a128a1117752b798/bd2dd05bc98743a4b1da7fa7fba967a7.jpg, createdBy=8b395549160, createdName=热带鱼哦哦, createdTime=Wed Jul 14 21:38:34 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999549, encodeId=aecb999549ee, content=高级, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5145541640, createdName=ms1000001425826697, createdTime=Wed Jul 14 21:30:16 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999494, encodeId=c71199949405, content=规律用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Wed Jul 14 18:53:20 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999485, encodeId=bfd0999485c8, content=完美, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeb04884224, createdName=1220956865, createdTime=Wed Jul 14 18:06:38 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 言西早

    规律用药

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1905174, encodeId=62dc19051e4db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun May 01 23:01:15 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999551, encodeId=5f4f9995510d, content=很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210714/3ef5dd581a1f4fa7a128a1117752b798/bd2dd05bc98743a4b1da7fa7fba967a7.jpg, createdBy=8b395549160, createdName=热带鱼哦哦, createdTime=Wed Jul 14 21:38:34 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999549, encodeId=aecb999549ee, content=高级, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5145541640, createdName=ms1000001425826697, createdTime=Wed Jul 14 21:30:16 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999494, encodeId=c71199949405, content=规律用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Wed Jul 14 18:53:20 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999485, encodeId=bfd0999485c8, content=完美, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeb04884224, createdName=1220956865, createdTime=Wed Jul 14 18:06:38 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 1220956865

    完美

    0

相关资讯

直播预告：瑞金医院刘霞主任：心律失常的临床诊断与心电图分析

6月28日晚19:00开课 | 课程形式：直播分享+问答互动+纸质书抽送

JACC：改良的非缺血扩张型心肌病患者室性心律失常和猝死风险分层

改良的非缺血扩张型心肌病患者室性心律失常和猝死风险分层

JAHA：美国总统选举与心律失常风险

2016年美国总统大选期间人群心律失常显著增加。这些研究结果表明，暴露于应激性社会政治事件可能会引发易感人群的心律失常。

Eur J Endocrinol：急性低血糖对2型糖尿病患者心律失常风险的影响

对于采用胰岛素治疗的2型糖尿病患者和没有糖尿病的健康对照个体，低血糖均可诱发临床显著的相似的心脏复极增强，这可能会增加严重心律失常和心源性猝死的易感性

JACC：影响复苏抢救过的心脏骤停患者生存率的因素

心律失常原因、室性心动过速/纤颤初始节律和白种人都是复苏性心脏骤停患者存活的独立预测因素

Circulation：非缺血性心室环状纤维化提示恶性心律失常风险大大增加！

存在环状模式的非缺血性LV瘢痕与恶性心律失常事件的发生风险密切相关

拓展阅读

JAHA：成年先天性心脏病患者心律失常的负担

相当比例的先天性心脏病患者在成年后会发展为心律失常。心律失常是成年先天性心脏病人群中重要的合并症，对医疗保健资源的使用和患者生存有重大影响。

Cardiovasc Diabetol：代谢功能障碍相关的脂肪变性肝病与新发心律失常有关

与匹配的对照者相比，活检证实的MASLD患者心律失常的发生率不高，但明显高于对照组，包括房颤、慢速心律失常、其他室上性心律失常和室性心律失常/心脏骤停。

Eur Heart J：不确定潜能的克隆造血预测心律失常

CHIP可能是心律失常事件一个新的危险因素，表明CHIP是心律失常预防和治疗的潜在调节靶点。

Science：心脏疤痕组织中的成纤维细胞直接调节心脏兴奋性和心律失常发生

在美国，每年有超过 350,000 名以前没有心脏病症状的人死于心源性猝死，大多数情况下，根本原因是心律失常。 虽然心脏中疤痕组织的数量与发生心律失常的可能性之间存在很强的相关性，但疤痕组织中的成纤维

JCEM：血清睾酮和性激素结合球蛋白与男性心律失常的关系

心律失常是一种日益严重的流行病，也是世界范围内一个主要的公共卫生问题。较低水平的睾酮和cFT与房颤和BA的风险增加有关。较高的cFT和SHBG水平与房颤风险增加相关。

Eur Heart J：癫痫与心律失常的长期风险

这项研究表明癫痫患者长期存在较高的心律失常风险，特别是那些使用卡马西平和丙戊酸的患者。这些结果强调需要对癫痫患者进行定期的心律监测和治疗，以减少心血管并发症的风险。